Metropolis Healthcare Limited (METROPOLIS) — Board Meeting | 20 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approves 10,000 OCRPS issuance for subsidiary Metropolis Quality Solutions
🔄 What Changed
OCRPS issuance may convert subsidiary into non-wholly owned entity within six years
🔮 What's Next
Conversion timeline up to six years pending term fulfillment
💡 Investor Takeaway
Potential dilution and subsidiary restructuring could affect valuation and control dynamics

Metropolis Healthcare announced that its wholly owned subsidiary Metropolis Quality Solutions Private Limited approved the issuance of 10,000 optionally convertible redeemable preference shares (OCRPS) with a face value of INR 10 each, aggregating to INR 100,000. The OCRPS may convert into equity shares at a 1:1 ratio, potentially converting MQSPL into a subsidiary rather than a wholly owned entity, with full conversion expected within six years. The transaction involves Dr. Puneet Kumar Nigam, a non-promoter individual, and is not a related party or slump sale. The issuance is outside any scheme of arrangement and does not trigger Regulation 37A disclosures.

📄 View Original Announcement (PDF)

About Metropolis Healthcare Limited (METROPOLIS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹12,082.27 Cr P/E: 25.0 ROE: 13.5% ROCE: 19.8% Div Yield: 0.86%

View full METROPOLIS stock details →

📡 Get AI alerts when METROPOLIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track METROPOLIS — Free

📊 More METROPOLIS filings

See all METROPOLIS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when METROPOLIS files new disclosures

Track METROPOLIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track METROPOLIS — Free

Free account · 2 AI queries/day